What is CEREBO, the brain tool developed indigenously? , Pg8

Key Highlights:

• CEREBO, a portable, non-invasive brain injury diagnostic tool, has been developed by ICMR, MDMS, AIIMS Bhopal, NIMHANS Bengaluru, and Bioscan Research.
• CEREBO detects intracranial bleeding and edema within a minute and is safe for infants and pregnant women.
• The device is designed for use in ambulances, trauma centers, rural clinics, and disaster response units.
• Clinical validation, regulatory approvals, and feasibility studies have been completed, paving the way for global adoption.
• TBIs are a leading cause of morbidity, mortality, disability and socio-economic losses in India.
• Road traffic injuries are the leading cause (60%) of TBIs followed by falls (20%-25%) and violence (10%).

Detailed Insights:

• CEREBO utilizes advanced near-infrared spectroscopy technology powered by machine learning to address the limitations of traditional TBI diagnostic methods.
• Traditional methods like the Glasgow Coma Scale (GCS) are prone to errors, while imaging techniques require specialized infrastructure and trained personnel.
• Health technology assessments recommend the adoption of CEREBO in tertiary care to accelerate CT scans, optimize triage, and reduce imaging costs.
• TBIs can result in long-term physical, cognitive, emotional, and behavioral impairments, with road accidents being a major cause in India.
• Early and accurate diagnosis of TBIs is crucial to prevent permanent brain damage and manage long-term consequences.

Scientific/Technical Concepts Involved:

• Near-infrared spectroscopy: A spectroscopic method that uses the near-infrared region of the electromagnetic spectrum.
• Glasgow Coma Scale (GCS): A neurological scale used to assess the level of consciousness in a person following a brain injury.
• Edema: Swelling caused by fluid accumulation in body tissues.